Cenas, Carlito R.
HRN: 22-45-12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2023
OXACILLIN 500MG (VIAL)
01/03/2023
01/10/2023
IV
1g
Q6
Inguinal Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes